Greenlight Biosciences Holdings Performance
The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Greenlight Biosciences are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Greenlight Biosciences Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Greenlight Biosciences is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 31.8 M | |
| Total Cashflows From Investing Activities | -26.5 M |
Greenlight |
Greenlight Biosciences Relative Risk vs. Return Landscape
If you would invest (100.00) in Greenlight Biosciences Holdings on December 28, 2024 and sell it today you would earn a total of 100.00 from holding Greenlight Biosciences Holdings or generate -100.0% return on investment over 90 days. Greenlight Biosciences Holdings is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Greenlight, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Greenlight Biosciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Greenlight Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Greenlight Biosciences Holdings, and traders can use it to determine the average amount a Greenlight Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| GRNA |
Based on monthly moving average Greenlight Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Greenlight Biosciences by adding Greenlight Biosciences to a well-diversified portfolio.
Greenlight Biosciences Fundamentals Growth
Greenlight Stock prices reflect investors' perceptions of the future prospects and financial health of Greenlight Biosciences, and Greenlight Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Greenlight Stock performance.
| Return On Equity | -3.67 | |||
| Return On Asset | -0.82 | |||
| Operating Margin | (14.94) % | |||
| Current Valuation | 90.5 M | |||
| Shares Outstanding | 151.68 M | |||
| Price To Book | 2.14 X | |||
| Price To Sales | 41.41 X | |||
| Revenue | 6.38 M | |||
| EBITDA | (153.99 M) | |||
| Cash And Equivalents | 44.13 M | |||
| Cash Per Share | 0.36 X | |||
| Total Debt | 80.48 M | |||
| Debt To Equity | 2.30 % | |||
| Book Value Per Share | 0.14 X | |||
| Cash Flow From Operations | (136.73 M) | |||
| Earnings Per Share | (1.12) X | |||
| Total Asset | 148.6 M | |||
| Retained Earnings | (420.64 M) | |||
Things to note about Greenlight Biosciences performance evaluation
Checking the ongoing alerts about Greenlight Biosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Greenlight Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Greenlight Biosciences is not yet fully synchronised with the market data | |
| Greenlight Biosciences has some characteristics of a very speculative penny stock | |
| Greenlight Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 6.38 M. Net Loss for the year was (167.06 M) with loss before overhead, payroll, taxes, and interest of (87.22 M). | |
| Greenlight Biosciences Holdings currently holds about 44.13 M in cash with (136.73 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.36. | |
| Roughly 43.0% of the company shares are held by company insiders |
- Analyzing Greenlight Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Greenlight Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining Greenlight Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Greenlight Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Greenlight Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Greenlight Biosciences' stock. These opinions can provide insight into Greenlight Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Greenlight Stock
If you are still planning to invest in Greenlight Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Greenlight Biosciences' history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |